24 May 2013
Keywords: avalon, signs, 200m, merck, co, accord, usa
Article | 12 March 2007
The USA's Avalon Pharmaceuticals has entered a drug discovery, development and commercialization collaboration with drug major
Merck & Co focused on ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 March 2007
23 May 2013
© 2013 thepharmaletter.com